In this regard, the immune modulator and tumor suppressor PDLIM2, which is expressed highest in the lung under normal conditions, is repressed in more than 90% of all human lung cancer cases when 50% of the expression level of lung tissues adjacent to tumors is used as the cut-off (19–30). The gene discussed is PDLIM2; the disease is lung carcinoma.